HCA Healthcare (NYSE:HCA) Stock: Insider Erica Rossitto Sells 3,500 Shares

HCA Healthcare, Inc. (NYSE:HCA) SVP Erica Rossitto sold 3,500 shares of the business’s stock in a transaction dated Tuesday, November 10th. The shares were sold at an average price of $505.81, for a total value of $1,770,335.00. Following the completion of the transaction, the senior vice president directly owned 13,426 shares of the company’s stock, valued at approximately $6,791,005.06. This trade represents a 20.68% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

HCA Healthcare Stock Up 0.3%

HCA Healthcare stock opened at $505.82 on Thursday. The business’s 50-day moving average price is $449.06 and its 200 day moving average price is $445.81. The firm has a market cap of $105.66 billion, a price-to-earnings ratio of 16.76, a price-to-earnings-growth ratio of 1.68 and a beta of 1.11. HCA Healthcare, Inc. has a 52 week low of $353.99 and a 52 week high of $556.52.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Tuesday, October 27th. The company reported $7.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.65 by $0.57. HCA Healthcare had a negative return on equity of 198.52% and a net margin of 8.61%. The company had revenue of $19.85 billion during the quarter, compared to the consensus estimate of $19.33 billion. During the same period in the previous year, the company posted $6.96 earnings per share. HCA Healthcare’s revenue for the quarter was up 3.6% on a year-over-year basis. Equities analysts expect that HCA Healthcare, Inc. will post 30.15 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 29th. Investors of record on Tuesday, December 15th will be paid a $0.78 dividend. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Tuesday, December 15th. HCA Healthcare’s payout ratio is currently 10.34%.

Hedge Funds Weigh In On HCA Healthcare

A number of hedge funds have recently made changes to their positions in HCA. Sunbelt Securities Inc. boosted its stake in HCA Healthcare by 171.7% during the 1st quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company’s stock worth $2,954,000 after purchasing an additional 3,945 shares during the last quarter. Sei Investments Co. raised its position in shares of HCA Healthcare by 27.5% in the first quarter. Sei Investments Co. now owns 467,796 shares of the company’s stock valued at $221,380,000 after buying an additional 100,764 shares during the last quarter. SEB Asset Management AB purchased a new position in shares of HCA Healthcare in the first quarter worth about $75,534,000. Darsana Capital Partners LP boosted its position in HCA Healthcare by 46.7% during the second quarter. Darsana Capital Partners LP now owns 1,100,000 shares of the company’s stock worth $428,879,000 after acquiring an additional 350,000 shares during the last quarter. Finally, Fund 1 Investments LLC purchased a new stake in HCA Healthcare during the 2nd quarter valued at about $975,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently commented on the stock. Cantor Fitzgerald restated an “overweight” rating on shares of HCA Healthcare in a research report on Friday, October 2nd. Mizuho set a $495.00 target price on HCA Healthcare in a research report on Wednesday, October 28th. Oppenheimer cut their price target on HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating for the company in a research note on Monday, July 27th. Sanford C. Bernstein reissued a “market perform” rating on shares of HCA Healthcare in a report on Wednesday, July 15th. Finally, Royal Bank Of Canada increased their price objective on shares of HCA Healthcare from $496.00 to $521.00 and gave the company an “outperform” rating in a report on Friday, October 30th. Sixteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $480.13.

Recent HCA Healthcare Headlines

Here are a few of the latest headlines about HCA:

• Neutral Sentiment: A Yahoo Finance article examines what drove HCA shares higher, but the supplied information does not specify the catalyst. Article: What Really Drove HCA Stock Higher?
• Neutral Sentiment: HCA Global’s reported long-term office-space lease in Hyderabad appears to concern an India-based business operation; its connection to publicly traded HCA Healthcare is unclear. Article: HCA Global Hyderabad Office Lease
• Negative Sentiment: A law firm is investigating investor claims involving HCA; this is an investigation announcement, not a finding of wrongdoing, but adds a potential legal overhang. Article: Pomerantz Investigates Investor Claims

About HCA Healthcare

HCA Healthcare is a healthcare services company that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency treatment, surgery, diagnostic services and specialized care across areas such as cancer and cardiovascular medicine. The company serves patients in the United States and the United Kingdom through its network of hospitals and outpatient facilities, including surgery centers, urgent care clinics and physician practices. Founded in 1968, HCA Healthcare is headquartered in Nashville, Tennessee.